SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) announced today that Michael Morrissey, Ph.D., the company’s president and chief executive officer, will present at the upcoming BIO CEO & Investor Conference at 11:30 a.m. EST / 8:30 a.m. PST on Monday, February 14, 2011 in New York. Dr. Morrissey will discuss the company’s development plans and priorities for cabozantinib (XL184), future data presentations and corporate strategy, and provide a general business update.
